788 Stock Overview
PKU HealthCare Corp.,Ltd. researches, develops, manufactures, and sells pharmaceutical products in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 788 from our risk checks.
PKU HealthCare Corp.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥4.90 |
| 52 Week High | CN¥7.85 |
| 52 Week Low | CN¥4.04 |
| Beta | 0.32 |
| 1 Month Change | -10.42% |
| 3 Month Change | -21.10% |
| 1 Year Change | -29.70% |
| 3 Year Change | -31.28% |
| 5 Year Change | -37.74% |
| Change since IPO | 22.57% |
Recent News & Updates
Shareholder Returns
| 788 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -8.2% | -0.7% | -0.2% |
| 1Y | -29.7% | -15.9% | -17.8% |
Return vs Industry: 000788 underperformed the CN Pharmaceuticals industry which returned -19% over the past year.
Return vs Market: 000788 underperformed the CN Market which returned -21.1% over the past year.
Price Volatility
| 788 volatility | |
|---|---|
| 788 Average Weekly Movement | 8.2% |
| Pharmaceuticals Industry Average Movement | 7.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 000788's share price has been volatile over the past 3 months.
Volatility Over Time: 000788's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1965 | 772 | Ping Dong Yuan | www.pku-hc.com |
PKU HealthCare Corp.,Ltd. researches, develops, manufactures, and sells pharmaceutical products in China. It offers products in various categories, including anti-tumor, psychoneurological, cardiovascular, immunosuppressive, antimicrobial, antipyretic and analgesic, digestive system, regulate immunity, oncology, anti-allergic, blood sugar regulation, mental disorder, and blood volume expansion.
PKU HealthCare Corp.,Ltd. Fundamentals Summary
| 788 fundamental statistics | |
|---|---|
| Market cap | CN¥2.92b |
| Earnings (TTM) | CN¥56.15m |
| Revenue (TTM) | CN¥2.18b |
52.0x
P/E Ratio1.3x
P/S RatioIs 788 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 788 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.18b |
| Cost of Revenue | CN¥1.44b |
| Gross Profit | CN¥733.72m |
| Other Expenses | CN¥677.57m |
| Earnings | CN¥56.15m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | 0.094 |
| Gross Margin | 33.72% |
| Net Profit Margin | 2.58% |
| Debt/Equity Ratio | 3.6% |
How did 788 perform over the long term?
See historical performance and comparison